CD73-BLOCKADE

European patent · EP3259288 · In force

Register entry

Publication number
EP3259288
Application number
EP16709299
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 19, 2016
Published
Dec 27, 2017
Granted
Jul 22, 2026
Protection ends at the latest
Feb 18, 2036
Next annual fee due
Feb 28, 2027
IPC classes
C07K 16/28 (2006.01)
C07K 16/40 (2006.01)
C07K 16/30 (2006.01)
Priority
US 201562118549 P 20.02.2015
US 201562133597 P 16.03.2015
US 201562188881 P 06.07.2015
WO PCT/EP2015/073370 09.10.2015
US 201662281841 P 22.01.2016
PCT application
PCT/EP2016/053539 19.02.2016
PCT publication
WO2016/131950 25.08.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 22, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 22.07.2026

Parties

Holder

Innate Pharma

117, Avenue de Luminy, 13009 Marseille, FR

Inventor

CHANTEUX, Stéphanie

13009 Marseille, FR

PATUREL, Carine

69280 Marcy l'Etoile, FR

PERROT, Ivan

13830 Roquefort la Bedoule, FR

GAUTHIER, Laurent

13008 Marseille, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.